Inspire Medical Systems, Inc. $INSP Shares Acquired by ING Groep NV

ING Groep NV boosted its holdings in Inspire Medical Systems, Inc. (NYSE:INSP) by 554.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 88,300 shares of the company’s stock after purchasing an additional 74,800 shares during the quarter. ING Groep NV owned approximately 0.30% of Inspire Medical Systems worth $8,144,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. CWM LLC raised its stake in Inspire Medical Systems by 216.1% during the fourth quarter. CWM LLC now owns 354 shares of the company’s stock worth $33,000 after acquiring an additional 242 shares during the period. Havemeyer Place LP bought a new stake in shares of Inspire Medical Systems in the 4th quarter worth approximately $39,000. V Square Quantitative Management LLC acquired a new position in Inspire Medical Systems during the 4th quarter valued at approximately $40,000. Larson Financial Group LLC grew its stake in Inspire Medical Systems by 21,266.7% during the 3rd quarter. Larson Financial Group LLC now owns 641 shares of the company’s stock worth $48,000 after buying an additional 638 shares during the last quarter. Finally, Daiwa Securities Group Inc. increased its position in Inspire Medical Systems by 38.7% in the second quarter. Daiwa Securities Group Inc. now owns 466 shares of the company’s stock worth $60,000 after buying an additional 130 shares during the period. 94.91% of the stock is owned by institutional investors and hedge funds.

Inspire Medical Systems Trading Up 0.3%

Inspire Medical Systems stock opened at $41.29 on Monday. Inspire Medical Systems, Inc. has a 52 week low of $38.91 and a 52 week high of $147.03. The stock has a market cap of $1.19 billion, a price-to-earnings ratio of 9.20, a PEG ratio of 4.25 and a beta of 0.73. The company’s 50-day moving average price is $48.93 and its two-hundred day moving average price is $73.20.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings results on Monday, May 4th. The company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.28) by $0.38. Inspire Medical Systems had a net margin of 14.33% and a return on equity of 10.35%. The company had revenue of $204.58 million during the quarter, compared to analyst estimates of $200.04 million. During the same period in the prior year, the business posted $0.10 EPS. The business’s revenue for the quarter was up 1.6% compared to the same quarter last year. Inspire Medical Systems has set its FY 2026 guidance at 0.750-1.250 EPS. Research analysts expect that Inspire Medical Systems, Inc. will post 0.91 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms have recently commented on INSP. Piper Sandler lowered shares of Inspire Medical Systems from an “overweight” rating to a “neutral” rating and lowered their price target for the stock from $85.00 to $55.00 in a research report on Tuesday, May 5th. Jefferies Financial Group reduced their target price on shares of Inspire Medical Systems from $81.00 to $66.00 and set a “hold” rating for the company in a research note on Thursday, February 12th. Oppenheimer restated a “market perform” rating on shares of Inspire Medical Systems in a research report on Thursday, May 7th. Wolfe Research lowered shares of Inspire Medical Systems from an “outperform” rating to a “peer perform” rating in a research note on Friday, February 13th. Finally, Zacks Research lowered Inspire Medical Systems from a “hold” rating to a “strong sell” rating in a report on Wednesday, May 13th. Four research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Inspire Medical Systems currently has a consensus rating of “Hold” and a consensus price target of $81.84.

About Inspire Medical Systems

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.